BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Artificial Intelligence in Healthcare M&A: On the Rise David H. Crean, managing director for Objective Capital Partners, highlights the latest trends in mergers and acquisition (M&A) activities involving companies with artificial intelligence/machine learning platforms and technologies and…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Life Sciences’ Growing Demand for AI Assets Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company Dassault Systemes Americas Corp.’s USD 5.9 billion acquisition of health tech…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Rethinking Healthcare Provision with AI As data and information proliferate at an exponential pace, many industries have turned to artificial intelligence to make sense of this information and deliver meaningful insights that can enhance performance. This…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME De-risking Drug Discovery with Artificial Intelligence On the supply side, AI appears to herald the prospect of de-risking the drug discovery process and doing away with many of the traditional time-consuming approaches at a juncture when…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Challenges to AI in Life Sciences With so many wild predictions being bandied around about AI’s potential to radically transform healthcare for the better, it is easy to lose sight of the fact that materialization of…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Christina M. Busmalis Director for Global Life Sciences & Go-To Market Leader for Europe & Asia Pacific, IBM Watson Health Christina Busmalis gives her insights into how AI and greater utilisation of real-world evidence is shaping…
BACK TO HOME Market Insight on Artificial Intelligence BACK TO HOME Demystifying Artificial Intelligence The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to expand at an impressive 20 percent compound annual growth rate in the…
HOMEPAGE Market Insight on Artificial Intelligence The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to expand at an impressive 20 percent compound annual growth rate in the period 2020 to 2024. Yet despite the massive hype and enthusiasm…
deloitte Vaccines BACK TO HOME Securing Trust in the COVID-19 Supply Chain: From Development & Delivery to Acceptance & Administration Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19 vaccine.[1] As rollouts become reality, stakeholders from across the globe will need…
Vaccines BACK TO HOME Manufacturing & Supply Chain Complexity Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological variability of the pathogen itself, which is the starting block of any vaccine, as well as the resulting…
Vaccines BACK TO HOME Population Health: Access & AntiVax Challenges Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global health institutions that vaccines save at least three million lives every year.…
Vaccines BACK TO HOME R&D: An Expanded Playbook The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox in 1976 by injecting them with cowpox pus is well-known. Over the past two centuries, vaccine development platforms have (thankfully) advanced leaps…
See our Cookie Privacy Policy Here